Identification of New Dystroglycan Complexes in Skeletal Muscle

Eric K. Johnson, Bin Li, Jung Hae Yoon, Kevin M. Flanigan, Paul T. Martin, James M. Ervasti, Federica MontanaroPLoS 2013 · DOI

Abstract

The dystroglycan complex contains the transmembrane protein β-dystroglycan and its interacting extracellular mucin-like protein α-dystroglycan. In skeletal muscle fibers, the dystroglycan complex plays an important structural role by linking the cytoskeletal protein dystrophin to laminin in the extracellular matrix. Mutations that affect any of the proteins involved in this structural axis lead to myofiber degeneration and are associated with muscular dystrophies and congenital myopathies. Because loss of dystrophin in Duchenne muscular dystrophy (DMD) leads to an almost complete loss of dystroglycan complexes at the myofiber membrane, it is generally assumed that the vast majority of dystroglycan complexes within skeletal muscle fibers interact with dystrophin. The residual dystroglycan present in dystrophin-deficient muscle is thought to be preserved by utrophin, a structural homolog of dystrophin that is up-regulated in dystrophic muscles. However, we found that dystroglycan complexes are still present at the myofiber membrane in the absence of both dystrophin and utrophin. Our data show that only a minority of dystroglycan complexes associate with dystrophin in wild type muscle. Furthermore, we provide evidence for at least three separate pools of dystroglycan complexes within myofibers that differ in composition and are differentially affected by loss of dystrophin. Our findings indicate a more complex role of dystroglycan in muscle than currently recognized and may help explain differences in disease pathology and severity among myopathies linked to mutations in DAPC members.

Introduction

In muscle biology, the Dystroglycan Complex (DGC) has long been viewed through the lens of the "bridge model." Composed of extracellular α-dystroglycan and transmembrane β-dystroglycan, its primary recognized function is to anchor the extracellular matrix (laminin) to the internal cytoskeleton (dystrophin). In conditions like Duchenne Muscular Dystrophy (DMD), where dystrophin is absent, dystroglycan levels at the cell membrane drop significantly. This led to the assumption that nearly all dystroglycan is physically bound to dystrophin. However, this study challenges that stoichiometry, investigating whether dystroglycan serves roles beyond this singular structural link.

Methods

The study employed a rigorous biochemical approach to quantify protein ratios in muscle:

  • Quantitative Western Blotting: Researchers established standard curves using purified proteins to calculate the exact molar ratios of dystrophin, dystroglycan, and laminin.
  • Immunodepletion: Specific antibodies were used to remove all dystrophin from muscle lysates to determine the amount of remaining, non-associated dystroglycan.
  • Genetic Models: The team analyzed wild-type, mdx (dystrophin-null), and mdx/Utrn−/− (dystrophin and utrophin-null) mice, as well as human DMD biopsies.
  • Proteomics: LC-MS/MS was used to identify novel binding partners that co-purify with β-dystroglycan independently of dystrophin.

Results

The 40:1 Surplus

Quantitative analysis revealed a surprising stoichiometric imbalance. In skeletal muscle, α-dystroglycan outnumbers dystrophin by a ratio of approximately 40 to 1. This massive excess indicates that the classic dystrophin-bound DGC represents only a small fraction of the total dystroglycan population.

Quantitative Western blot for α-dystroglycan (α-DG) showing the standard curve used to calculate molar ratios in muscle.

Identification of a "Free" Dystroglycan Pool

Immunodepletion experiments confirmed that the majority of the dystroglycan complex is not physically anchored to dystrophin. Even after stripping dystrophin from lysates, a significant pool of β-dystroglycan remained in the supernatant. Furthermore, dystroglycan persists at the myofiber membrane in "double knockout" mice lacking both dystrophin and utrophin, proving its ability to localize to the membrane independently of these large anchor proteins.

Immunodepletion of dystrophin (DYS) demonstrating that a significant pool of β-dystroglycan (βDG) remains in the supernatant (Post lane) after DYS is removed.

Novel Molecular Partners

Proteomic screening identified Cavin-1 (PTRF) and β2-syntrophin as high-confidence partners for the dystrophin-independent dystroglycan pool. Cavin-1 is a known regulator of membrane repair and caveolae, suggesting that these "free" DGCs may have specialized signaling or maintenance functions.

Discussion

These findings redefine the DGC as a multi-pool system rather than a single structural unit. The authors propose three distinct populations: dystrophin-associated, utrophin-associated, and "free" DGCs. While the structural bridge is essential for muscle stability, the abundance of independent complexes suggests a more nuanced role in muscle physiology, potentially involving membrane repair via Cavin-1. Future work is needed to determine how these independent pools are anchored to the cytoskeleton and why their presence is insufficient to prevent the severe muscle wasting seen in the absence of dystrophin.

Summary updated

Abstract

The dystroglycan complex contains the transmembrane protein β-dystroglycan and its interacting extracellular mucin-like protein α-dystroglycan. In skeletal muscle fibers, the dystroglycan complex plays an important structural role by linking the cytoskeletal protein dystrophin to laminin in the extracellular matrix. Mutations that affect any of the proteins involved in this structural axis lead to myofiber degeneration and are associated with muscular dystrophies and congenital myopathies. Because loss of dystrophin in Duchenne muscular dystrophy (DMD) leads to an almost complete loss of dystroglycan complexes at the myofiber membrane, it is generally assumed that the vast majority of dystroglycan complexes within skeletal muscle fibers interact with dystrophin. The residual dystroglycan present in dystrophin-deficient muscle is thought to be preserved by utrophin, a structural homolog of dystrophin that is up-regulated in dystrophic muscles. However, we found that dystroglycan complexes are still present at the myofiber membrane in the absence of both dystrophin and utrophin. Our data show that only a minority of dystroglycan complexes associate with dystrophin in wild type muscle. Furthermore, we provide evidence for at least three separate pools of dystroglycan complexes within myofibers that differ in composition and are differentially affected by loss of dystrophin. Our findings indicate a more complex role of dystroglycan in muscle than currently recognized and may help explain differences in disease pathology and severity among myopathies linked to mutations in DAPC members.
BibTeX
@inproceedings{johnson2013identification,
  author = {Eric K. Johnson and Bin Li and Jung Hae Yoon and Kevin M. Flanigan and Paul T. Martin and James M. Ervasti and Federica Montanaro},
  title = {{Identification of New Dystroglycan Complexes in Skeletal Muscle}},
  booktitle = {PLoS},
  year = {2013},
  doi = {10.1371/journal.pone.0073224},
}
Figure